{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:04:44Z","timestamp":1789419884134,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011760","name":"Chettinad Academy of Research and Education","doi-asserted-by":"publisher","award":["004\/Regr.\/AR-Research\/2022-06"],"award-info":[{"award-number":["004\/Regr.\/AR-Research\/2022-06"]}],"id":[{"id":"10.13039\/501100011760","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00210-023-02608-0","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T03:02:35Z","timestamp":1688785355000},"page":"3407-3415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Nanocargos designed with synthetic and natural polymers for ovarian cancer management"],"prefix":"10.1007","volume":"396","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1109-1705","authenticated-orcid":false,"given":"Sharon Sofini","family":"PS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3702-7461","authenticated-orcid":false,"given":"Arina","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4441-7863","authenticated-orcid":false,"given":"Balasubramanian","family":"Deepika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3655-4689","authenticated-orcid":false,"given":"Saranya","family":"Udayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1365-5722","authenticated-orcid":false,"given":"Moupriya","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9968-6078","authenticated-orcid":false,"given":"Dibyajit","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0475-2544","authenticated-orcid":false,"given":"Agnishwar","family":"Girigoswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1554-5241","authenticated-orcid":false,"given":"Koyeli","family":"Girigoswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"key":"2608_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.msec.2018.11.035","volume":"96","author":"JP Abriata","year":"2019","unstructured":"Abriata JP, Turatti RC, Luiz MT et al (2019) Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles. Mater Sci Eng C Mater Biol Appl 96:347\u2013355. https:\/\/doi.org\/10.1016\/j.msec.2018.11.035","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"8","key":"2608_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/1061186X.2018.1564923","volume":"27","author":"L Alizadeh","year":"2019","unstructured":"Alizadeh L, Zarebkohan A, Salehi R, Ajjoolabady A, Rahmati-Yamchi M (2019) Chitosan-based nanotherapeutics for ovarian cancer treatment. J Drug Target 27(8):839\u2013852. https:\/\/doi.org\/10.1080\/1061186X.2018.1564923","journal-title":"J Drug Target"},{"issue":"1","key":"2608_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/2212798412666220527154707","volume":"13","author":"D Balasubramanian","year":"2022","unstructured":"Balasubramanian D, Girigoswami A, Girigoswami K (2022) Antimicrobial, pesticidal and food preservative applications of lemongrass oil nanoemulsion: a mini-review. Recent Adv Food Nutr Agric 13(1):51\u201358. https:\/\/doi.org\/10.2174\/2212798412666220527154707","journal-title":"Recent Adv Food Nutr Agric"},{"key":"2608_CR4","doi-asserted-by":"publisher","unstructured":"Balasubramanian D, Girigoswami A, Girigoswami K (2023) Nano resveratrol and its anticancer activity. Curr Appl Sci Technol. https:\/\/doi.org\/10.55003\/cast.2022.03.23.010","DOI":"10.55003\/cast.2022.03.23.010"},{"issue":"1","key":"2608_CR5","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1080\/10717544.2022.2058645","volume":"29","author":"S Bhattacharya","year":"2022","unstructured":"Bhattacharya S, Anjum MM, Patel KK (2022) Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery. Drug Deliv 29(1):1060\u20131074. https:\/\/doi.org\/10.1080\/10717544.2022.2058645","journal-title":"Drug Deliv"},{"key":"2608_CR6","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.2147\/IJN.S247114","volume":"15","author":"B Bortot","year":"2020","unstructured":"Bortot B, Mongiat M, Valencic E et al (2020) Nanotechnology-based cisplatin intracellular delivery to enhance chemo-sensitivity of ovarian cancer. Int J Nanomedicine 15:4793\u20134810. https:\/\/doi.org\/10.2147\/IJN.S247114","journal-title":"Int J Nanomedicine"},{"key":"2608_CR7","doi-asserted-by":"publisher","first-page":"120079","DOI":"10.1016\/j.ijpharm.2020.120079","volume":"592","author":"N Brandhonneur","year":"2021","unstructured":"Brandhonneur N, Boucaud Y, Verger A et al (2021) Molybdenum cluster loaded PLGA nanoparticles as efficient tools against epithelial ovarian cancer. Int J Pharm 592:120079. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.120079","journal-title":"Int J Pharm"},{"issue":"1","key":"2608_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/jfb10010004","volume":"10","author":"E Calzoni","year":"2019","unstructured":"Calzoni E, Cesaretti A, Polchi A, Di Michele A, Tancini B, Emiliani C (2019) Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J Funct Biomater 10(1):4. https:\/\/doi.org\/10.3390\/jfb10010004","journal-title":"J Funct Biomater"},{"issue":"4","key":"2608_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/jphp.12860","volume":"70","author":"S Chaurasiya","year":"2018","unstructured":"Chaurasiya S, Mishra V (2018) Biodegradable nanoparticles as theranostics of ovarian cancer: an overview. J Pharm Pharmacol 70(4):435\u2013449. https:\/\/doi.org\/10.1111\/jphp.12860","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"2608_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/pharmaceutics11060282","volume":"11","author":"L Duse","year":"2019","unstructured":"Duse L, Agel MR, Pinnapireddy SR et al (2019) Photodynamic therapy of ovarian carcinoma cells with curcumin-loaded biodegradable polymeric nanoparticles. Pharmaceutics 11(6):282. https:\/\/doi.org\/10.3390\/pharmaceutics11060282","journal-title":"Pharmaceutics"},{"key":"2608_CR11","doi-asserted-by":"publisher","first-page":"102655","DOI":"10.1016\/j.jddst.2021.102655","volume":"64","author":"O Esim","year":"2021","unstructured":"Esim O, Gedik ME, Dogan AL, Gunaydin G, Hascicek C (2021) Development of carboplatin loaded bovine serum albumin nanoparticles and evaluation of its effect on an ovarian cancer cell line. J. Drug Deliv Sci Technol 64:102655. https:\/\/doi.org\/10.1016\/j.jddst.2021.102655","journal-title":"J. Drug Deliv Sci Technol"},{"issue":"1","key":"2608_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/21691401.2019.1573737","volume":"47","author":"L Faramarzi","year":"2019","unstructured":"Faramarzi L, Dadashpour M, Sadeghzadeh H, Mahdavi M, Zarghami N (2019) Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells. Artif Cells Nanomed Biotechnol 47(1):737\u2013746. https:\/\/doi.org\/10.1080\/21691401.2019.1573737","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"6","key":"2608_CR13","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.31557\/APJCP.2022.23.6.1951","volume":"23","author":"A Firouzai-Amandi","year":"2022","unstructured":"Firouzai-Amandi A, Tarahomi M, RahmaniYoushanlouie H et al (2022) Development, characterization, and in vitro evaluation of cytotoxic activity of rutin loaded PCL-PEG nanoparticles against Skov3 ovarian cancer cell. Asian Pac J Cancer Prev 23(6):1951\u20131957. https:\/\/doi.org\/10.31557\/APJCP.2022.23.6.1951","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"2608_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/pharmaceutics12050439","volume":"12","author":"AI Fraguas-S\u00e1nchez","year":"2020","unstructured":"Fraguas-S\u00e1nchez AI, Torres-Su\u00e1rez AI, Cohen M et al (2020) PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: in vitro and in ovo assessment. Pharmaceutics 12(5):439. https:\/\/doi.org\/10.3390\/pharmaceutics12050439","journal-title":"Pharmaceutics"},{"key":"2608_CR15","doi-asserted-by":"publisher","first-page":"601626","DOI":"10.3389\/fphar.2021.601626","volume":"12","author":"A Gagliardi","year":"2021","unstructured":"Gagliardi A, Giuliano E, Venkateswararao E et al (2021) Biodegradable polymeric nanoparticles for drug delivery to solid tumors. Front Pharmacol 12:601626. https:\/\/doi.org\/10.3389\/fphar.2021.601626","journal-title":"Front Pharmacol"},{"key":"2608_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.colsurfb.2018.03.046","volume":"167","author":"KA Gawde","year":"2018","unstructured":"Gawde KA, Sau S, Tatiparti K et al (2018) Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers. Colloids Surf B 167:8\u201319. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.03.046","journal-title":"Colloids Surf B"},{"issue":"7","key":"2608_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/14328917.2021.2023288","volume":"26","author":"Narayan S Geeva","year":"2022","unstructured":"Geeva Narayan S (2022) Insight into the preparation of biopolymeric nanoparticles with lithium and their cellular uptake studies using PC 12 cells. Mater Res Innov 26(7):415\u201326. https:\/\/doi.org\/10.1080\/14328917.2021.2023288","journal-title":"Mater Res Innov"},{"key":"2608_CR18","doi-asserted-by":"publisher","unstructured":"Girigoswami K, Pallavi P, Girigoswami A (2020) Targeting cancer stem cells by nanoenabled drug delivery. Cancer Cell Int 313\u201337. https:\/\/doi.org\/10.1007\/978-981-15-5120-8_17","DOI":"10.1007\/978-981-15-5120-8_17"},{"issue":"1","key":"2608_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1871530320666200515115723","volume":"21","author":"K Girigoswami","year":"2021","unstructured":"Girigoswami K, Girigoswami A (2021) A review on the role of nanosensors in detecting cellular miRNA expression in colorectal cancer. Endocr Metab Immune Disord Drug Targets 21(1):12\u201326. https:\/\/doi.org\/10.2174\/1871530320666200515115723","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"3","key":"2608_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/1567201816666181119112410","volume":"16","author":"V Haribabu","year":"2019","unstructured":"Haribabu V, Sharmiladevi P, Akhtar N, Farook AS, Girigoswami K, Girigoswami A (2019) Label free ultrasmall fluoromagnetic ferrite-clusters for targeted cancer imaging and drug delivery. Curr Drug Deliv 16(3):233\u2013241. https:\/\/doi.org\/10.2174\/1567201816666181119112410","journal-title":"Curr Drug Deliv"},{"issue":"1","key":"2608_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/17458080.2022.2110241","volume":"17","author":"P Hou","year":"2022","unstructured":"Hou P, Kuang H, Deng W, Lei Y (2022) Immobilized copper nanoparticles on biodegradable magnetic starch composite: investigation of its ovarian cancer, cytotoxicity, and antioxidant effects. J Exp Nanosci 17(1):496\u2013508. https:\/\/doi.org\/10.1080\/17458080.2022.2110241","journal-title":"J Exp Nanosci"},{"key":"2608_CR22","doi-asserted-by":"publisher","first-page":"119314","DOI":"10.1016\/j.ijpharm.2020.119314","volume":"582","author":"S Indoria","year":"2020","unstructured":"Indoria S, Singh V, Hsieh M-F (2020) Recent advances in theranostic polymeric nanoparticles for cancer treatment: a review. Int J Pharm 582:119314. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119314","journal-title":"Int J Pharm"},{"issue":"4","key":"2608_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gocm.2021.09.001","volume":"1","author":"B Iyshwarya","year":"2021","unstructured":"Iyshwarya B, Mohammed V, Veerabathiran R (2021) Genetics of endometriosis and its association with ovarian cancer. Clin Obstet Gynecol 1(4):177\u2013185. https:\/\/doi.org\/10.1016\/j.gocm.2021.09.001","journal-title":"Clin Obstet Gynecol"},{"key":"2608_CR24","doi-asserted-by":"publisher","first-page":"109452","DOI":"10.1016\/j.inoche.2022.109452","volume":"140","author":"N Ji","year":"2022","unstructured":"Ji N, Dong C, Jiang J (2022) Evaluation of antioxidant, cytotoxicity, and anti-ovarian cancer properties of the Fe3O4@ CS-starch\/Cu bio-nanocomposite. Inorg Chem Commun 140:109452. https:\/\/doi.org\/10.1016\/j.inoche.2022.109452","journal-title":"Inorg Chem Commun"},{"issue":"14","key":"2608_CR25","doi-asserted-by":"publisher","first-page":"880","DOI":"10.21037\/atm-20-5028","volume":"8","author":"H Jiang","year":"2020","unstructured":"Jiang H, Liang G, Dai M et al (2020) Preparation of doxorubicin-loaded collagen-PAPBA nanoparticles and their anticancer efficacy in ovarian cancer. Ann Transl Med 8(14):880. https:\/\/doi.org\/10.21037\/atm-20-5028","journal-title":"Ann Transl Med"},{"issue":"9","key":"2608_CR26","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1016\/j.bioactmat.2021.01.034","volume":"6","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Feng X, Zou H, Xu W, Zhuang X (2021) Poly(l-glutamic acid)-cisplatin nanoformulations with detachable PEGylation for prolonged circulation half-life and enhanced cell internalization. Bioact Mater 6(9):2688\u20132697. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.01.034","journal-title":"Bioact Mater"},{"key":"2608_CR27","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.jddst.2020.101529","volume":"56","author":"M Joshi","year":"2020","unstructured":"Joshi M, Nagarsenkar M, Prabhakar B (2020) Albumin nanocarriers for pulmonary drug delivery: an attractive approach. J Drug Deliv Sci Technol 56:101529. https:\/\/doi.org\/10.1016\/j.jddst.2020.101529","journal-title":"J Drug Deliv Sci Technol"},{"key":"2608_CR28","doi-asserted-by":"publisher","first-page":"121189","DOI":"10.1016\/j.biomaterials.2021.121189","volume":"279","author":"J Kim","year":"2021","unstructured":"Kim J, Shim MK, Cho Y-J et al (2021) The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis. Biomaterials. 279:121189. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121189","journal-title":"Biomaterials."},{"issue":"4","key":"2608_CR29","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3390\/nano11041048","volume":"11","author":"SL Levit","year":"2021","unstructured":"Levit SL, Tang C (2021) Polymeric nanoparticle delivery of combination therapy with synergistic effects in ovarian cancer. Nanomaterials 11(4):1048. https:\/\/doi.org\/10.3390\/nano11041048","journal-title":"Nanomaterials"},{"key":"2608_CR30","doi-asserted-by":"publisher","first-page":"119986","DOI":"10.1016\/j.ijpharm.2020.119986","volume":"591","author":"Y Li","year":"2020","unstructured":"Li Y, Gao Y, Zhang X, Guo H, Gao H (2020) Nanoparticles in precision medicine for ovarian cancer: from chemotherapy to immunotherapy. Int J Pharm 591:119986. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119986","journal-title":"Int J Pharm"},{"key":"2608_CR31","doi-asserted-by":"publisher","first-page":"110038","DOI":"10.1016\/j.msec.2019.110038","volume":"105","author":"MT Luiz","year":"2019","unstructured":"Luiz MT, Abriata JP, Raspantini GL et al (2019) In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy. Mater Sci Eng C Mater Biol Appl 105:110038. https:\/\/doi.org\/10.1016\/j.msec.2019.110038","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"2608_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bcab.2018.11.029","volume":"17","author":"SK Metkar","year":"2019","unstructured":"Metkar SK, Girigoswami K (2019) Diagnostic biosensors in medicine\u2013a review. Biocatal Agric Biotechnol 17:271\u2013283. https:\/\/doi.org\/10.1016\/j.bcab.2018.11.029","journal-title":"Biocatal Agric Biotechnol"},{"issue":"4","key":"2608_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.22037\/ijpr.2021.114575.14923","volume":"20","author":"SMS Mirnezami","year":"2021","unstructured":"Mirnezami SMS, Heydarinasab A, Akbarzadehkhyavi A, Adrjmand M (2021) Development and optimization of lipid-polymer hybrid nanoparticles containing melphalan using central composite design and its effect on ovarian cancer cell lines. Iran. J. Pharm. Res. 20(4):213\u2013228. https:\/\/doi.org\/10.22037\/ijpr.2021.114575.14923","journal-title":"Iran. J. Pharm. Res."},{"issue":"2","key":"2608_CR34","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1021\/acsabm.1c01107","volume":"5","author":"A Moammeri","year":"2022","unstructured":"Moammeri A, Abbaspour K, Zafarian A et al (2022) pH-responsive, adorned nanoniosomes for codelivery of cisplatin and epirubicin: synergistic treatment of breast cancer. ACS Appl Bio Mater 5(2):675\u2013690. https:\/\/doi.org\/10.1021\/acsabm.1c01107","journal-title":"ACS Appl Bio Mater"},{"key":"2608_CR35","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jphotobiol.2018.04.022","volume":"183","author":"S Padhi","year":"2018","unstructured":"Padhi S, Kapoor R, Verma D, Panda AK, Iqbal Z (2018) Formulation and optimization of topotecan nanoparticles: in vitro characterization, cytotoxicity, cellular uptake and pharmacokinetic outcomes. J Photochem Photobiol B 183:222\u2013232. https:\/\/doi.org\/10.1016\/j.jphotobiol.2018.04.022","journal-title":"J Photochem Photobiol B"},{"issue":"6","key":"2608_CR36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2174\/1573413718666211222162041","volume":"18","author":"P Pallavi","year":"2022","unstructured":"Pallavi P, Sharmiladevi P, Haribabu V, Girigoswami K, Girigoswami A (2022) A nano approach to formulate photosensitizers for photodynamic therapy. Curr Nanosci 18(6):675\u2013689. https:\/\/doi.org\/10.2174\/1573413718666211222162041","journal-title":"Curr Nanosci"},{"key":"2608_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-023-04475-0","author":"P Pallavi","year":"2023","unstructured":"Pallavi P, Harini K, Crowder S et al (2023) Rhodamine-conjugated anti-Stokes gold nanoparticles with higher ROS quantum yield as theranostic probe to arrest cancer and MDR bacteria. Appl Biochem Biotechnol. https:\/\/doi.org\/10.1007\/s12010-023-04475-0","journal-title":"Appl Biochem Biotechnol"},{"issue":"4","key":"2608_CR38","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1021\/acsbiomaterials.0c00163","volume":"6","author":"Q Pan","year":"2020","unstructured":"Pan Q, Tian J, Zhu H et al (2020) Tumor-targeting polycaprolactone nanoparticles with codelivery of paclitaxel and IR780 for combinational therapy of drug-resistant ovarian cancer. ACS Biomater Sci Eng 6(4):2175\u20132185. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c00163","journal-title":"ACS Biomater Sci Eng"},{"key":"2608_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-022-09666-6","author":"GB Patil","year":"2022","unstructured":"Patil GB, Borse DM, More MP, Patil DA (2022) Gossypol-embedded casein nanoparticles for potential targeting of ovarian cancer: formulation, characterization, and anticancer activity. J Pharm Innov. https:\/\/doi.org\/10.1007\/s12247-022-09666-6","journal-title":"J Pharm Innov"},{"key":"2608_CR40","doi-asserted-by":"publisher","first-page":"111755","DOI":"10.1016\/j.colsurfb.2021.111755","volume":"203","author":"M Potara","year":"2021","unstructured":"Potara M, Nagy-Simon T, Focsan M et al (2021) Folate-targeted pluronic-chitosan nanocapsules loaded with IR780 for near-infrared fluorescence imaging and photothermal-photodynamic therapy of ovarian cancer. Colloids Surf B 203:111755. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111755","journal-title":"Colloids Surf B"},{"issue":"1","key":"2608_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1006\/gyno.2002.6807","volume":"87","author":"CC Sun","year":"2002","unstructured":"Sun CC, Bodurka DC, Donato ML et al (2002) Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time? Gynecol Oncol 87(1):118\u2013128. https:\/\/doi.org\/10.1006\/gyno.2002.6807","journal-title":"Gynecol Oncol"},{"issue":"5","key":"2608_CR42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2174\/1568009617666170109150430","volume":"17","author":"Z Sun","year":"2017","unstructured":"Sun Z, Duan R, Xing D, Pang X, Li Z, Chen X (2017) Recent advances in application of poly-epsilon-caprolactone and its derivative copolymers for controlled release of anti-tumor drugs. Curr Cancer Drug Targets 17(5):445\u2013455. https:\/\/doi.org\/10.2174\/1568009617666170109150430","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"2608_CR43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/s42003-022-03966-w","volume":"5","author":"R Taheri-Ledari","year":"2022","unstructured":"Taheri-Ledari R, Zolfaghari E, Zarei-Shokat S, Kashtiaray A, Maleki A (2022) A magnetic antibody-conjugated nano-system for selective delivery of Ca(OH)2 and taxotere in ovarian cancer cells. Commun Biol 5(1):995. https:\/\/doi.org\/10.1038\/s42003-022-03966-w","journal-title":"Commun Biol"},{"key":"2608_CR44","doi-asserted-by":"publisher","first-page":"118729","DOI":"10.1016\/j.ijpharm.2019.118729","volume":"573","author":"S Vandghanooni","year":"2020","unstructured":"Vandghanooni S, Eskandani M, Barar J, Omidi Y (2020) Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells. Int J Pharm 573:118729. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118729","journal-title":"Int J Pharm"},{"issue":"7","key":"2608_CR45","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1166\/jbn.2022.3384","volume":"18","author":"L Yang","year":"2022","unstructured":"Yang L, Zhang Y, Yang H, Yu L, Rohani S (2022) Evaluation of cytotoxicity and anti-angiogenesis induced by crocetin-delivering alginate hydrogel\/chitosan nanoparticle carrier system on human ovarian cancer cell line (A2780): an in vitro evaluation. J Biomed Nanotechnol 18(7):1746\u20131754. https:\/\/doi.org\/10.1166\/jbn.2022.3384","journal-title":"J Biomed Nanotechnol"},{"key":"2608_CR46","doi-asserted-by":"publisher","first-page":"102198","DOI":"10.2174\/1573413718666211222162041","volume":"61","author":"A Zafar","year":"2021","unstructured":"Zafar A, Alruwaili NK, Imam SS et al (2021) Novel nanotechnology approaches for diagnosis and therapy of breast, ovarian and cervical cancer in female: a review. J Drug Deliv Sci Technol 61:102198. https:\/\/doi.org\/10.2174\/1573413718666211222162041","journal-title":"J Drug Deliv Sci Technol"},{"key":"2608_CR47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.biopha.2018.09.039","volume":"108","author":"W Zheng","year":"2018","unstructured":"Zheng W, Li M, Lin Y, Zhan X (2018) Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer. Biomed Pharmacother 108:565\u2013573. https:\/\/doi.org\/10.1016\/j.biopha.2018.09.039","journal-title":"Biomed Pharmacother"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02608-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02608-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02608-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T02:07:20Z","timestamp":1699841240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02608-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2608"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02608-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,8]]},"assertion":[{"value":"1 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}